Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 23,500
+450 (1.95%)
At close: Feb 27, 2026
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 1.05 trillion as of February 27, 2026. Its market cap has increased by 584.69% in one year.
Market Cap
1.05T
Enterprise Value
1.00T
Revenue
46.65B
Ranking
n/a
PE Ratio
15.52
Stock Price
23,500.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 1.05T, an increase of 464.37%. That is a compound annual growth rate of 327.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.05T | 21.28% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 2.77T |
| Chabiotech | 1.99T |
| GI Innovation | 1.03T |
| Pharmicell | 974.47B |
| Medy-Tox | 904.14B |
| Proteina | 898.13B |
| MEDIPOST | 857.93B |
| Green Cross Holdings | 723.25B |